KRAS and neoplasm: As H1437, A549, and H1299 have either activated, oncogenically mutated K-Ras (A549) or WT K-Ras genes (H1437 and H1299), IKKα can function as an NSCLC tumor suppressor with or without oncogenic K-Ras.